1
|
Goswami MT, Weh E, Subramanya S, Weh KM, Durumutla HB, Hager H, Miller N, Chaudhury S, Andren A, Sajjakulnukit P, Besirli CG, Lyssiotis CA, Wubben TJ. Glutaminase deficiency in rod photoreceptors disrupts nonessential amino acid levels to activate the integrated stress response and induce rapid degeneration. bioRxiv 2024:2024.03.26.582525. [PMID: 38586045 PMCID: PMC10996599 DOI: 10.1101/2024.03.26.582525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/09/2024]
Abstract
The bioenergetic demand of photoreceptors rivals that of cancer cells, and numerous metabolic similarities exist between these cells. Glutamine (Gln) anaplerosis via the tricarboxylic acid (TCA) cycle provides biosynthetic intermediates and is a hallmark of cancer metabolism. In this process, Gln is first converted to glutamate via glutaminase (GLS), which is a crucial pathway in many cancer cells. To date, no study has been undertaken to examine the role of Gln metabolism in vivo in photoreceptors. Here, mice lacking GLS in rod photoreceptors were generated. Animals lacking GLS experienced rapid photoreceptor degeneration with concomitant functional loss. Gln has multiple roles in metabolism including redox balance, biosynthesis of nucleotides and amino acids, and supplementing the TCA cycle. Few alterations were noted in redox balance. Unlabeled targeted metabolomics demonstrated few changes in glycolytic and TCA cycle intermediates, which corresponded with a lack of significant changes in mitochondrial function. GLS deficiency in rod photoreceptors did decrease the fractional labelling of TCA cycle intermediates when provided uniformly labeled 13C-Gln in vivo. However, supplementation with alpha-ketoglutarate provided only marginal rescue of photoreceptor degeneration. Nonessential amino acids, glutamate and aspartate, were decreased in the retina of mice lacking GLS in rod photoreceptors. In accordance with this amino acid deprivation, the integrated stress response (ISR) was found to be activated with decreased global protein synthesis. Importantly, supplementation with asparagine delayed photoreceptor degeneration to a greater degree than alpha-ketoglutarate. These data show that GLS-mediated Gln catabolism is essential for rod photoreceptor amino acid biosynthesis, function, and survival.
Collapse
Affiliation(s)
- Moloy T. Goswami
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Eric Weh
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Shubha Subramanya
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Katherine M. Weh
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Hima Bindu Durumutla
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
- Molecular and Developmental Biology Graduate Program, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229
| | - Heather Hager
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Nicholas Miller
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Sraboni Chaudhury
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Anthony Andren
- Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109
| | - Peter Sajjakulnukit
- Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109
| | - Cagri G. Besirli
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| | - Costas A. Lyssiotis
- Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109
- Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI 48109
- Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109
| | - Thomas J. Wubben
- Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105
| |
Collapse
|
2
|
Williams C, Swisher S, Miller N, Pinn-Woodcock T, Austin C, Hsiao SH, Arenas-Gamboa AM, Tiller R, Thacker T, Taetzsch S, Franklin-Guild R, Cutter L, Quance C, Hung CC, Maddox CW, Ernst M, Guarino C, Lanka S, Garcia-Gonzalez DG, Slager S, Sunavala Z, Brown C, Negron M, Pieracci EG. Human exposures to Brucella canis from a pregnant dog during an international flight: Public health risks, diagnostic challenges and future considerations. Zoonoses Public Health 2024. [PMID: 38459616 DOI: 10.1111/zph.13121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Revised: 02/22/2024] [Accepted: 02/24/2024] [Indexed: 03/10/2024]
Abstract
AIMS This report documents the exposure of passengers and crew of a commercial international flight to the zoonotic pathogen Brucella canis after an infected dog aborted in the passenger cabin of the aircraft. This case demonstrates the challenges associated with brucellosis screening and the risks that airline personnel, airport employees and travellers face when animals with unrecognized zoonotic infections are transported. METHODS/RESULTS The public health investigation of this case was conducted by the Centers for Disease Control, the Illinois Department of Health and the Illinois Department of Agriculture, in collaboration with a local veterinary clinic and several academic and federal diagnostic laboratories. It included an extensive diagnostic evaluation of the dam and aborted foetuses to confirm a diagnosis of canine brucellosis. Passengers, airline personnel and staff from the veterinary clinic where the dogs were treated underwent risk assessments, and clinic staff also received detailed guidance regarding infection prevention practices. CONCLUSIONS Animal shelters and breeding programs are recommended to screen dogs routinely for brucellosis, but it is not unusual for domestic or imported animals to have unknown health histories, including the dog's brucellosis status, at the time of purchase, adoption, or re-homing. Testing recommendations and requirements vary by state, making it challenging for state public health and animal health agencies to monitor and respond appropriately. This case highlights the importance of Brucella spp. screening in sexually intact dogs prior to breeding, purchase, or domestic or international transportation of the dogs. The transportation of pregnant dogs may present a previously unrecognized public health threat in addition to contributing to unnecessary stress and health risks for pregnant animals.
Collapse
Affiliation(s)
- Cara Williams
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Samantha Swisher
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- Epidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Nicholas Miller
- Elk Grove Veterinary Specialty & Emergency, Elk Grove Village, Illinois, USA
| | - Toby Pinn-Woodcock
- Department of Population Medicine and Diagnostic Sciences, Animal Health Diagnostic Center, Cornell University, Ithaca, New York, USA
| | - Connie Austin
- Illinois Department of Public Health, Springfield, Illinois, USA
| | - Shih-Hsuan Hsiao
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Angela M Arenas-Gamboa
- Department of Veterinary Pathobiology, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA
| | - Rebekah Tiller
- Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Tyler Thacker
- Mycobacteria and Brucella Section, National Veterinary Services Laboratories, United States Department of Agriculture, Animal & Plant Health Inspection Service, Ames, Iowa, USA
| | - Sara Taetzsch
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Rebecca Franklin-Guild
- Department of Population Medicine and Diagnostic Sciences, Animal Health Diagnostic Center, Cornell University, Ithaca, New York, USA
| | - Laurel Cutter
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Christine Quance
- Mycobacteria and Brucella Section, National Veterinary Services Laboratories, United States Department of Agriculture, Animal & Plant Health Inspection Service, Ames, Iowa, USA
| | - Chien-Che Hung
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Carol W Maddox
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Mark Ernst
- Illinois Department of Agriculture, Springfield, Illinois, USA
| | - Cassandra Guarino
- Department of Population Medicine and Diagnostic Sciences, Animal Health Diagnostic Center, Cornell University, Ithaca, New York, USA
| | - Saraswathi Lanka
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
| | - Daniel G Garcia-Gonzalez
- Department of Veterinary Pathobiology, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, USA
| | - Staci Slager
- Illinois Department of Agriculture, Springfield, Illinois, USA
| | - Zenia Sunavala
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Clive Brown
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Maria Negron
- Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Emily G Pieracci
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| |
Collapse
|
3
|
Xu L, McCandless L, Miller N, Alessio A, Morrison J. Machine-Learned Algorithms to Predict the Risk of Pneumothorax Requiring Chest Tube Placement after Lung Biopsy. J Vasc Interv Radiol 2023; 34:2155-2161. [PMID: 37619941 DOI: 10.1016/j.jvir.2023.08.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 06/29/2023] [Accepted: 08/15/2023] [Indexed: 08/26/2023] Open
Abstract
PURPOSE To develop a machine-learned algorithm to predict the risk of postlung biopsy pneumothorax requiring chest tube placement (CTP) to facilitate preprocedural decision making, optimize patient care, and improve resource allocation. MATERIALS AND METHODS This retrospective study collected clinical and imaging features of biopsy samples obtained from patients with lung nodule biopsy and included information from 59 procedures resulting in pneumothorax requiring CTP and randomly selected 67 procedures without CTP (convenience sample). The data were divided into 70 and 30 as training and testing sets, respectively. Conventional machine-learned binary classifiers were explored with preprocedural imaging and clinical data as input features and CTP as the output. RESULTS There was no single pathognomonic imaging or predictive clinical feature. For the independent test set under the high-specificity mode, a decision tree, logistic regression, and Naïve Bayes classifier achieved accuracies of identifying CTP at 0.79, 0.93, and 0.89 and area under receiver operating curves (AUROCs) of 0.68, 0.76, and 0.82, respectively. Under high-sensitivity mode, a decision tree, logistic regression, and Naïve Bayes achieved accuracies of identifying CTP of 0.60, 0.45, and 0.60 with AUROCs of 0.71, 0.81, and 0.82, respectively. High importance features included lesion character, chronic obstructive pulmonary disease, lesion depth, and age. A coarse decision tree requiring 4 inputs achieved comparable performance as other methods and previous machine learning prediction studies. CONCLUSIONS The results support the possibility of predicting pneumothorax requiring CTP after biopsy based on an automated decision support, reliant on readily available preprocedural information.
Collapse
Affiliation(s)
- Lu Xu
- Biomedical Engineering, Michigan State University, East Lansing, Michigan; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan; College of Human Medicine, Michigan State University, East Lansing, Michigan.
| | - Lane McCandless
- College of Human Medicine, Michigan State University, East Lansing, Michigan
| | - Nicholas Miller
- College of Human Medicine, Michigan State University, East Lansing, Michigan
| | - Adam Alessio
- Biomedical Engineering, Michigan State University, East Lansing, Michigan; Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan
| | - James Morrison
- College of Human Medicine, Michigan State University, East Lansing, Michigan; Advanced Radiology Services, Grand Rapids, Michigan
| |
Collapse
|
4
|
Banerjee A, Pitts N, Miller N. Alliance for a Cavity-Free Future (ACFF) UK Chapter: meeting summary. Br Dent J 2023; 235:959-960. [PMID: 38102265 DOI: 10.1038/s41415-023-6606-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Accepted: 11/06/2023] [Indexed: 12/17/2023]
Affiliation(s)
| | - Nigel Pitts
- Chair of Global ACFF, Co-Chair of ACFF UK Chapter, Dean of Research Impact at King´s College London,, Director of Dental Innovation and Impact for the Faculty of Dentistry, Oral and Craniofacial Sciences, UK.
| | | |
Collapse
|
5
|
David SP, Dunnenberger HM, Choi S, DePersia A, Ilbawi N, Ward C, Wake DT, Khandekar JD, Shannon Y, Hughes K, Miller N, Mangold KA, Sabatini LM, Helseth DL, Xu J, Sanders A, Kaul KL, Hulick PJ. Personalized medicine in a community health system: the NorthShore experience. Front Genet 2023; 14:1308738. [PMID: 38090148 PMCID: PMC10713750 DOI: 10.3389/fgene.2023.1308738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Accepted: 11/06/2023] [Indexed: 02/01/2024] Open
Abstract
Genomic and personalized medicine implementation efforts have largely centered on specialty care in tertiary health systems. There are few examples of fully integrated care systems that span the healthcare continuum. In 2014, NorthShore University HealthSystem launched the Center for Personalized Medicine to catalyze the delivery of personalized medicine. Successful implementation required the development of a scalable family history collection tool, the Genetic and Wellness Assessment (GWA) and Breast Health Assessment (BHA) tools; integrated pharmacogenomics programming; educational programming; electronic medical record integration; and robust clinical decision support tools. To date, more than 225,000 patients have been screened for increased hereditary conditions, such as cancer risk, through these tools in primary care. More than 35,000 patients completed clinical genetic testing following GWA or BHA completion. An innovative program trained more than 100 primary care providers in genomic medicine, activated with clinical decision support and access to patient genetic counseling services and digital healthcare tools. The development of a novel bioinformatics platform (FLYPE) enabled the incorporation of genomics data into electronic medical records. To date, over 4,000 patients have been identified to have a pathogenic or likely pathogenic variant in a gene with medical management implications. Over 33,000 patients have clinical pharmacogenomics data incorporated into the electronic health record supported by clinical decision support tools. This manuscript describes the evolution, strategy, and successful multispecialty partnerships aligned with health system leadership that enabled the implementation of a comprehensive personalized medicine program with measurable patient outcomes through a genomics-enabled learning health system model that utilizes implementation science frameworks.
Collapse
Affiliation(s)
- Sean P. David
- Department of Family Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Family Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Outcomes Research Network, NorthShore University HealthSystem, Evanston, IL, United States
| | - Henry M. Dunnenberger
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Sarah Choi
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Allison DePersia
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Outcomes Research Network, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
| | - Nadim Ilbawi
- Department of Family Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Family Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
| | - Christopher Ward
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Dyson T. Wake
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Janardan D. Khandekar
- Department of Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Kellogg Cancer Center, NorthShore University HealthSystem, Evanston, IL, United States
| | - Yvette Shannon
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
| | - Kristen Hughes
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Nicholas Miller
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Kathy A. Mangold
- Department of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
| | - Linda M. Sabatini
- Department of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
| | - Donald L. Helseth
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Jianfeng Xu
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
| | - Alan Sanders
- Center for Psychiatric Genetics, Department of Psychiatry and Behavioral Sciences, NorthShore University HealthSystem, Evanston, IL, United States
- Departments of Psychiatry and Behavioral Neuroscience, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
| | - Karen L. Kaul
- Outcomes Research Network, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
- Department of Pathology, NorthShore University HealthSystem, Evanston, IL, United States
| | - Peter J. Hulick
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Outcomes Research Network, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Medicine, NorthShore University HealthSystem, Evanston, IL, United States
- Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL, United States
| |
Collapse
|
6
|
Bunn DC, Miller N. Natural Occurrence and Analysis of Nosema sp. Infection in the Adult Population of Western Bean Cutworm in Michigan. Environ Entomol 2023; 52:39-46. [PMID: 36469425 DOI: 10.1093/ee/nvac102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Indexed: 06/17/2023]
Abstract
An understanding of population dynamics and insect biology is important for effective crop management strategies. Biotic factors such as pathogens play a large role on the fitness and dynamics of insect populations. Microsporidia are obligate intracellular parasites that infect more than 150 insect species and range from sublethal and chronic to fast acting and deadly. The western bean cutworm, Striacosta albicosta (Smith) (Lepidoptera: Noctuidae), is a pest of both corn (Zea maize L. [Poales: Poaceae]) and dry beans (Phaseolus sp L. [Fabales: Fabaceae]) that is infected by a microsporidian parasite from the genus Nosema (Microsporidia: Nosematidae). Unfortunately, little is known about the interactions between the Nosema sp. (Microsporidia: Nosematidae) infecting the western bean cutworm and its prevalence and effects on the host population. This is especially true for the western bean cutworm population that has settled in the Great Lakes region over the last two decades. Using field caught samples and phase contrast microscopy, no consistent trends in pathogen load were observed over the course of the western bean cutworm flight season. A weak, but statistically significant relationship was observed between male body weight and pathogen load. Overall, we found a 100% prevalence of infection in the adult western bean cutworm population in Michigan.
Collapse
Affiliation(s)
- Dakota C Bunn
- Department of Biological Sciences, Illinois Institute of Technology, Chicago, IL 60616, USA
| | - Nicholas Miller
- Department of Biological Sciences, Illinois Institute of Technology, Chicago, IL 60616, USA
| |
Collapse
|
7
|
Asif KS, Novakovic R, Ortega-Gutierrez S, Nguyen T, Jagolino-Cole AL, Jumaa MA, Al-Bayati AR, Liebeskind DS, Nour M, Castonguay A, Desai S, Yavagal D, Mokin M, Sheth S, Teleb MS, Kumar P, Hartman J, Miller N, Jhadav A, Hassan AE, Mehta B. Abstract TMP46: Large Vessel Occlusion Stroke Knowledge And Clinical Training In Emergency Medical Service Personnel In The United States. Stroke 2023. [DOI: 10.1161/str.54.suppl_1.tmp46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Background:
Stroke education of emergency medical service (EMS) personnel improves stroke recognition, prenotification, and thrombolytic delivery. Prehospital identification of large vessel occlusion (LVO) stroke may facilitate the creation of a regional bypass protocol and improvement of intrahospital and interhospital workflows. However, the current status of EMS personnel’s knowledge of LVO, their stroke severity assessment training, and preferences in educational methods have not been studied. We conducted an EMS survey across the United States.
Methods:
The Society of Vascular and Interventional Neurology (SVIN) in collaboration with EMS-World created an online questionnaire distributed to all subscribers of EMS-World involved in pre-hospital work. It included 12 multiple-choice questions to test participants on LVO knowledge, stroke center certification levels, prior LVO education, and preferences on educational content delivery.
Results:
The survey email was opened by 1830 subscribers out of whom 1107 (60%) completed the survey across 50 states in the United States. Respondents identified themselves as paramedics/EMTs (91.4%), ground critical care (5.7%) and flight crew (2.9%). The number of stroke patients that survey participants transported in the past year was <10 for 618 (55.8%), 10 to 25 for 332 (30%), and >25 (14.2%). Two hundred eighty-five (25.8%) participants answered both LVO knowledge questions correctly and 379 (34.2%) answered one correctly. Only 128 (11.6%) correctly identified all types of centers with thrombectomy capability. Although 877 (79.2%) were familiar with at least one stroke severity scale, 376 (34%) denied receiving training to perform them. Five sixty-seven (51.2%) respondents preferred in-person training for LVO training and 429 (38.8%) an online training program. About half of all respondents (535,48%) picked 'lack of standardized LVO training' as the greatest hurdle to pre-hospital LVO management.
Conclusion:
EMS providers in the United States reported inadequate LVO training and demonstrated gaps in knowledge of LVO, stroke severity scales, and stroke center levels. Systematic efforts to enhance and standardize the educational content and delivery of LVO education are urgently needed.
Collapse
Affiliation(s)
- Kaiz S Asif
- Neuroendovascular, Ascension, IL and Univ of Illinois, Chicago, IL
| | | | | | | | | | | | | | | | - May Nour
- UCLA Depts of Neurology-Radiology, Los Angeles, CA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Turer R, Champion J, Rothman B, Dunn H, Jenkins K, Evernham O, Barrett T, Jones I, Miller N. 69 Improving Critical Care Documentation in an Academic Emergency Department via Point-of-Documentation Decision Support. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
9
|
Patel M, Williams J, Bachman M, Cyr J, Cabanas J, Miller N, Gorstein L, Turcios H, Malcolm JT, Brice J. 406EMF Early Fluid Delivery by Emergency Medical Services for Sepsis Using a Novel Rapid Infusion Device. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Avanceña ALV, Miller N, Kim DeLuca E, Iott B, Mauri A, Eisenberg D, Hutton DW. Estimation of Potential Deaths Averted From Hypothetical US Income Support Policies. JAMA Health Forum 2022; 3:e221537. [PMID: 35977246 PMCID: PMC9187947 DOI: 10.1001/jamahealthforum.2022.1537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Accepted: 04/22/2022] [Indexed: 11/14/2022] Open
Abstract
Question How many deaths among working-age US adults can hypothetical income support policies, such as universal basic income, the modified LIFT Act, poverty alleviation, and negative income tax, potentially avert? Findings In this multicohort modeling study that simulated US adults age 18 to 64 years over 5 to 40 years, broad income support policies, like universal basic income, were estimated to avert the most deaths among working-age adults, although targeted approaches, like poverty alleviation, may also avert thousands of deaths among low-income populations. Results were sensitive to several inputs, primarily the income group–specific mortality rates used. Meaning The results of this study suggest that income support policies may prevent thousands of deaths among working-age US adults. Importance Income has a negative, nonlinear association with all-cause mortality. Income support policies may prevent deaths among low-income populations by raising their incomes. Objective To estimate the deaths that could be averted among working-age adults age 18 to 64 years with hypothetical income support policies in the US. Design, Setting, and Population An open, multicohort life-table model was developed that simulated working-age adults age 18 to 64 years in the US over 5 to 40 years. Publicly available household income data and previous estimates of the income-mortality association were used to generate mortality rates by income group. Deterministic sensitivity analyses were conducted to evaluate the effect of parameter uncertainty and various model assumptions on the findings. Interventions In addition to a no-intervention scenario, 4 hypothetical income support policies were modeled: universal basic income, modified LIFT Act, poverty alleviation, and negative income tax. Main Outcome and Measures The main outcome was the number of deaths averted, which was calculated by subtracting the number of deaths experienced in the no-intervention scenario from the number of deaths experienced with the various income support policies. Results Base-case assumptions used average mortality rates by age, sex, and income group, a 20-year time horizon, and a 3-year lag time. Universal basic income worth $12 000 per year per individual was estimated to avert the most deaths among working-age adults (42 000-104 000 per year), followed by a negative income tax that guaranteed an income of 133% of the federal poverty level (19 000-67 000 per year). A modified LIFT Act that provided $6000 to individuals with annual household incomes less than $100 000 was estimated to avert 17 000 to 52 000 deaths per year. A targeted approach that alleviated poverty was estimated to prevent 12 000 to 32 000 deaths among the lowest-income, working-age adult population. Results were most sensitive to several inputs and assumptions, primarily the income-based mortality rates, analytic time horizon, and assumed time lag between when a policy was implemented and when individuals experienced the mortality benefit of having higher incomes. Conclusions and Relevance In this modeling study, 4 hypothetical income support policies were estimated to avert thousands of deaths among working-age US adults every year. Additional research is needed to understand the true association of income gains with mortality. Discussions about the costs and benefits of income support policies should include potential gains in health.
Collapse
Affiliation(s)
- Anton L. V. Avanceña
- Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor
| | - Nicholas Miller
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor
| | - Ellen Kim DeLuca
- Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor
| | - Bradley Iott
- Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor
- School of Information, University of Michigan, Ann Arbor
- Now with School of Medicine, University of California, San Francisco
| | - Amanda Mauri
- Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor
- Department of Political Science, University of Michigan, Ann Arbor
| | - Daniel Eisenberg
- Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles
| | - David W. Hutton
- Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor
- Department of Industrial and Operations Engineering, College of Engineering, University of Michigan, Ann Arbor
| |
Collapse
|
11
|
Redij T, McKee JA, Do P, Campbell JA, Ma J, Li Z, Miller N, Srikanlaya C, Zhang D, Hua X, Li Z. 2-Aminothiophene derivatives as a new class of positive allosteric modulators of glucagon-like peptide 1 receptor. Chem Biol Drug Des 2022; 99:857-867. [PMID: 35313084 DOI: 10.1111/cbdd.14039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2021] [Revised: 02/08/2022] [Accepted: 03/05/2022] [Indexed: 11/29/2022]
Abstract
We report the discovery of two new 2-aminothiophene based small molecule positive allosteric modulators (PAMs) of glucagon-like peptide 1 receptor (GLP-1R) for the treatment of type 2 diabetes. One of the chemotypes, (S-1), has a molecular weight of 239 g/mol, the smallest molecule among all reported GLP-1R PAMs. When combined with GLP-1 peptide, S-1 increased the GLP-1R activity in a dose-dependent manner in a cell-based assay. When combined with the peptide agonist of vasoactive intestinal polypeptide receptor 1 (VIPR1), S-1 showed no specific activity on VIPR1, another class B GPCR present in the same HEK293-CREB cell line. Insulin secretion studies found S-1 combined with GLP-1 increased insulin secretion by 1.5-fold at 5 μM. In a mechanistic study, evidence is provided that the synergistic effect of S-1 with GLP-1 may be partly due to the enhanced impact on CREB based phosphorylation. Given the favorable profile of these chemotypes, the work reported herein suggests that 2-aminothiophene derivatives are a new and promising class of GLP-1R PAMs.
Collapse
Affiliation(s)
- Tejashree Redij
- Department of Biological Sciences, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| | - James A McKee
- Department of Chemistry & Biochemistry, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| | - Phu Do
- Department of Chemistry & Biochemistry, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| | - Jeffrey A Campbell
- Department of Chemistry & Biochemistry, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| | - Jian Ma
- Department of Cancer Biology, Diabetes Research Center (DRC), University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Zhiyu Li
- Department of Pharmaceutical Sciences, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| | - Nicholas Miller
- Department of Chemistry & Biochemistry, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| | - Chananchida Srikanlaya
- Department of Chemistry & Biochemistry, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| | - Dianzheng Zhang
- Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA
| | - Xianxin Hua
- Department of Cancer Biology, Diabetes Research Center (DRC), University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Zhijun Li
- Department of Biological Sciences, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA.,Department of Chemistry & Biochemistry, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA
| |
Collapse
|
12
|
Lally P, Miller N, Roberts A, Beeken RJ, Greenfield DM, Potts HWW, Counsell N, Latimer N, Thomas C, Smith L, Gath J, Kennedy F, Martin C, Wyld L, Fisher A. An app with brief behavioural support to promote physical activity after a cancer diagnosis (APPROACH): study protocol for a pilot randomised controlled trial. Pilot Feasibility Stud 2022; 8:74. [PMID: 35351187 PMCID: PMC8961486 DOI: 10.1186/s40814-022-01028-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Accepted: 03/09/2022] [Indexed: 11/22/2022] Open
Abstract
Background There are multiple health benefits from participating in physical activity after a cancer diagnosis, but many people living with and beyond cancer (LWBC) are not meeting physical activity guidelines. App-based interventions offer a promising platform for intervention delivery. This trial aims to pilot a theory-driven, app-based intervention that promotes brisk walking among people living with and beyond cancer. The primary aim is to investigate the feasibility and acceptability of study procedures before conducting a larger randomised controlled trial (RCT). Methods This is an individually randomised, two-armed pilot RCT. Patients with localised or metastatic breast, prostate, or colorectal cancer, who are aged 16 years or over, will be recruited from a single hospital site in South Yorkshire in the UK. The intervention includes an app designed to encourage brisk walking (Active 10) supplemented with habit-based behavioural support in the form of two brief telephone/video calls, an information leaflet, and walking planners. The primary outcomes will be feasibility and acceptability of the study procedures. Demographic and medical characteristics will be collected at baseline, through self-report and hospital records. Secondary outcomes for the pilot (assessed at 0 and 3 months) will be accelerometer measured and self-reported physical activity, body mass index (BMI) and waist circumference, and patient-reported outcomes of quality of life, fatigue, sleep, anxiety, depression, self-efficacy, and habit strength for walking. Qualitative interviews will explore experiences of participating or reasons for declining to participate. Parameters for the intended primary outcome measure (accelerometer measured average daily minutes of brisk walking (≥ 100 steps/min)) will inform a sample size calculation for the future RCT and a preliminary economic evaluation will be conducted. Discussion This pilot study will inform the design of a larger RCT to investigate the efficacy and cost-effectiveness of this intervention in people LWBC. Trial registration ISRCTN registry, ISRCTN18063498. Registered 16 April 2021. Supplementary Information The online version contains supplementary material available at 10.1186/s40814-022-01028-w.
Collapse
Affiliation(s)
- P Lally
- Behavioural Science and Health, UCL, Gower Street, London, WC1E 6BT, UK.
| | - N Miller
- Behavioural Science and Health, UCL, Gower Street, London, WC1E 6BT, UK
| | - A Roberts
- Behavioural Science and Health, UCL, Gower Street, London, WC1E 6BT, UK
| | - R J Beeken
- Leeds Institute of Health Sciences, University of Leeds, Leeds, LS2 9JT, UK
| | - D M Greenfield
- Sheffield Teaching Hospitals NHS FT, Weston Park Hospital, Sheffield, S10 2SJ, UK
| | - H W W Potts
- Institute of Health Informatics, University College London, London, UK
| | - N Counsell
- Cancer Research UK & UCL Cancer Trials Centre, Cancer Institute, University College London, London, UK
| | - N Latimer
- School of Health and Related Research, University of Sheffield, Sheffield, S1 4DA, UK
| | - C Thomas
- School of Health and Related Research, University of Sheffield, Sheffield, S1 4DA, UK
| | - L Smith
- The Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, CB1 1PT, UK
| | - J Gath
- Yorkshire and Humberside Consumer Research Panel
| | - F Kennedy
- Leeds Institute of Health Sciences, University of Leeds, Leeds, LS2 9JT, UK
| | - C Martin
- Leeds Institute of Health Sciences, University of Leeds, Leeds, LS2 9JT, UK
| | - L Wyld
- Department of Oncology and Metabolism, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK
| | - A Fisher
- Behavioural Science and Health, UCL, Gower Street, London, WC1E 6BT, UK
| |
Collapse
|
13
|
Severson P, Kellner W, Franovic A, Miller N, Murphy E, Martin E, Williams R. 40P Real-world clinical genomic analysis of patients with BRAF mutated cancers identifies BRAF class II and III as a population of unmet medical need. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.01.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
14
|
Pitts NB, Newton JT, Pow R, Miller N, Mayne C. Dental Policy Lab 3: towards oral and dental health through partnership. Br Dent J 2021; 231:764-768. [PMID: 34921274 PMCID: PMC8683370 DOI: 10.1038/s41415-021-3733-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Accepted: 10/20/2021] [Indexed: 11/29/2022]
Abstract
The third and last of the successful Alliance for a Cavity-Free Future (ACFF)/King's College London Dental Policy Lab series, held in 2019, focused on outlining how dental and oral health industries could benefit from enabling positive behaviour change in patients and the public, allowing progress towards caries reduction. During a two-day event, experts from across public health, dentists, global multi-national corporations and dental industry start-ups discussed the issue, collaboratively developing ideas around policy, technology, messaging and engagement for change. An analysis of the current trends in oral health laid out how the implications for industry and corporate social responsibility were identified as crucial. The report and accompanying infographic explored in this paper have been well received and acted as a catalyst for future developments in the area. Many elements must be focused on to successfully influence public and patient behaviour change. Prevention-focused practice models must be implemented to ensure patients are provided with optimal preventive interventions, minimising caries risk and the need for future treatment. Changes in regulation and public policy must be seen to free up the dental and oral health industries to innovate and push for developments in caries-reducing technology. Oral health must be placed on corporate social responsibility agendas to ensure that industry is focused on seeing health improvements.
Collapse
Affiliation(s)
- Nigel B Pitts
- Faculty of Dentistry, Oral & Craniofacial Sciences, King´s College London, Tower Wing, Guy´s Hospital, London, SE1 9RT, UK.
| | - J Tim Newton
- Faculty of Dentistry, Oral & Craniofacial Sciences, King´s College London, Tower Wing, Guy´s Hospital, London, SE1 9RT, UK
| | - Ross Pow
- Power of Numbers, Cambridgeshire, UK
| | - Nicholas Miller
- Faculty of Dentistry, Oral & Craniofacial Sciences, King´s College London, Tower Wing, Guy´s Hospital, London, SE1 9RT, UK
| | - Catherine Mayne
- Faculty of Dentistry, Oral & Craniofacial Sciences, King´s College London, Tower Wing, Guy´s Hospital, London, SE1 9RT, UK
| |
Collapse
|
15
|
Marsden D, Miller VR, Chettiath T, Johnson B, Sarafrazi S, Willcock A, Miller N. METABOLIC MYOPATHIES. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
16
|
Avanceña ALV, DeLuca EK, Iott B, Mauri A, Miller N, Eisenberg D, Hutton DW. Income and Income Inequality Are a Matter of Life and Death. What Can Policymakers Do About It? Am J Public Health 2021; 111:1404-1408. [PMID: 34464177 DOI: 10.2105/ajph.2021.306301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Anton L V Avanceña
- Anton L. V. Avanceña, Ellen Kim DeLuca, Bradley Iott, and Amanda Mauri are PhD candidates in health services organization and policy at the University of Michigan, Ann Arbor. Nicholas Miller is a recent MPH graduate in epidemiology at the University of Michigan, Ann Arbor. Daniel Eisenberg is with the Fielding School of Public Health, University of California, Los Angeles. David W. Hutton is with the School of Public Health, University of Michigan, Ann Arbor
| | - Ellen Kim DeLuca
- Anton L. V. Avanceña, Ellen Kim DeLuca, Bradley Iott, and Amanda Mauri are PhD candidates in health services organization and policy at the University of Michigan, Ann Arbor. Nicholas Miller is a recent MPH graduate in epidemiology at the University of Michigan, Ann Arbor. Daniel Eisenberg is with the Fielding School of Public Health, University of California, Los Angeles. David W. Hutton is with the School of Public Health, University of Michigan, Ann Arbor
| | - Bradley Iott
- Anton L. V. Avanceña, Ellen Kim DeLuca, Bradley Iott, and Amanda Mauri are PhD candidates in health services organization and policy at the University of Michigan, Ann Arbor. Nicholas Miller is a recent MPH graduate in epidemiology at the University of Michigan, Ann Arbor. Daniel Eisenberg is with the Fielding School of Public Health, University of California, Los Angeles. David W. Hutton is with the School of Public Health, University of Michigan, Ann Arbor
| | - Amanda Mauri
- Anton L. V. Avanceña, Ellen Kim DeLuca, Bradley Iott, and Amanda Mauri are PhD candidates in health services organization and policy at the University of Michigan, Ann Arbor. Nicholas Miller is a recent MPH graduate in epidemiology at the University of Michigan, Ann Arbor. Daniel Eisenberg is with the Fielding School of Public Health, University of California, Los Angeles. David W. Hutton is with the School of Public Health, University of Michigan, Ann Arbor
| | - Nicholas Miller
- Anton L. V. Avanceña, Ellen Kim DeLuca, Bradley Iott, and Amanda Mauri are PhD candidates in health services organization and policy at the University of Michigan, Ann Arbor. Nicholas Miller is a recent MPH graduate in epidemiology at the University of Michigan, Ann Arbor. Daniel Eisenberg is with the Fielding School of Public Health, University of California, Los Angeles. David W. Hutton is with the School of Public Health, University of Michigan, Ann Arbor
| | - Daniel Eisenberg
- Anton L. V. Avanceña, Ellen Kim DeLuca, Bradley Iott, and Amanda Mauri are PhD candidates in health services organization and policy at the University of Michigan, Ann Arbor. Nicholas Miller is a recent MPH graduate in epidemiology at the University of Michigan, Ann Arbor. Daniel Eisenberg is with the Fielding School of Public Health, University of California, Los Angeles. David W. Hutton is with the School of Public Health, University of Michigan, Ann Arbor
| | - David W Hutton
- Anton L. V. Avanceña, Ellen Kim DeLuca, Bradley Iott, and Amanda Mauri are PhD candidates in health services organization and policy at the University of Michigan, Ann Arbor. Nicholas Miller is a recent MPH graduate in epidemiology at the University of Michigan, Ann Arbor. Daniel Eisenberg is with the Fielding School of Public Health, University of California, Los Angeles. David W. Hutton is with the School of Public Health, University of Michigan, Ann Arbor
| |
Collapse
|
17
|
Miller N, Pasternak Y, Dornstein C, Haiki. Herzberger E, Zada N, Hemi R, Wiser A. P–640 High physical activity and ovarian reserve: A prospective study of normo-ovulatory professional athletes. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
Is high physical activity (HPA) associated with low ovarian reserve in normo-ovulatory, reproductive-age women?
Summary answer
HPA does not affect ovarian reserve negatively.
What is known already
HPA is associated with menstrual irregularities and subsequent potential infertility, probably through hypothalamic neuroendocrine pathways. However, it is not yet known whether HPA influences the ovarian reserves of normo-ovulatory, reproductive-age women.
Study design, size, duration
This observational, cross-sectional study compared 30 professional female athletes who were engaged in HPA for at least 3 years prior to study recruitment, with high International Physical Activity Questionnaire (IPAQ) scores and 30 women who did not engage in physical activity. The study was conducted at a tertiary medical center from 2017–2020.
Participants/materials, setting, methods
Physically active, normo-ovulatory women (n = 30), ages 20–35 years were recruited from The Wingate Institute, the Israeli National Institute for Sport Excellence. Non-physically active women (n = 30), matched by age and BMI to the HPA group, were recruited from the hospital staff. Both groups were evaluated for ovarian reserve markers on day 2–5 of the menstrual cycle, including follicular stimulating hormone (FSH), antral follicle count (AFC), anti-Mullerian hormone (AMH) and Inhibin B.
Main results and the role of chance
The average age of the athletes (HPA group) was 30.1±2.1 years and of the nonactive (control) group 31.6±3.8 years (p = 0.071). BMI of the 2 groups was similar (22.6±2.4 vs. 21.3±2.6; p = 0.075) for the HPA and control groups, respectively. Regarding ovarian reserve, no significant differences were observed between the HPA group and the control group with respect to FSH (p = 0.304), AFC (p = 0.27), AMH (0.507) or Inhibin B (p = 0.074). For the HPA group, older age at menarche was positively associated with AFC (p = 0.008) and AMH (p = 0.009) and not with FSH levels (p = 0.313). For the nonactive group, no significant association between age at menarche and FSH levels, AFC or AMH was found (p = 0.433, p = 0.274 and p = 0.163, respectively). Additionally, for the HPA group, duration of physical activity per week (hours) was not significantly associated with FSH levels, AFC or AMH (p = 0.619, p = 0.608 or p = 0.997, respectively).
Limitations, reasons for caution
Although we investigated the ovarian reserves of 30 women engaged in HPA, a larger cohort would provide more information. Information on diet and sleep habits was not evaluated and may result in some confounding. Moreover, it would be more informative if we also followed these women regarding fecundability and fertility.
Wider implications of the findings: This study demonstrated that HPA may not negatively affect ovarian reserve markers. These findings may provide reassurance for women who are engaged in HPA and attempting pregnancy. Further research needs s to be confuted.
Trial registration number
0247–16
Collapse
Affiliation(s)
- N Miller
- Meir Medical Center, OB/GYN, Kfar Saba, Israel
| | - Y Pasternak
- Meir Medical Center, OB/GYN, Kfar Saba, Israel
| | - C Dornstein
- Tel Aviv University, Tel Aviv university, Tel Aviv, Israel
| | | | - N Zada
- Sheba Medical Center, Endocrinology Labs, Ramat Gan, Israel
| | - R Hemi
- Sheba Medical Center, Endocrinology Labs, Ramat Gan, Israel
| | - A Wiser
- Meir Medical Center, OB/GYN, Kfar Saba, Israel
| |
Collapse
|
18
|
Avanceña AL, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021; 74:1286-1294. [PMID: 33326815 PMCID: PMC8177741 DOI: 10.1016/j.jhep.2020.12.004] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 11/24/2020] [Accepted: 12/03/2020] [Indexed: 12/19/2022]
Abstract
BACKGROUND & AIMS Alcohol use treatment such as medication-assisted therapies (MATs) and counseling are available and effective in promoting alcohol abstinence. We sought to explore the cost-effectiveness of different alcohol use treatments among patients with compensated alcohol-related cirrhosis (AC). METHODS We simulated a cohort of patients with compensated AC receiving care from a hepatology clinic over their lifetimes. We estimated costs (in 2017 US$) and benefits in terms of quality-adjusted life years (QALYs) gained from healthcare and societal perspectives. Transition probabilities, costs, and health utility weights were taken from the literature. Treatment effects of FDA-approved MATs (acamprosate and naltrexone) and non-FDA approved MATs (baclofen, gabapentin, and topiramate) and counseling were based on a study of employer-insured patients with AC. We calculated incremental cost-effectiveness ratios (ICERs) and performed one-way and probabilistic sensitivity analyses to understand the impact of parameter uncertainty. RESULTS Compared to a do-nothing scenario, MATs and counseling were found to be cost-saving from a healthcare perspective, which means that they provide more benefits with less costs than no intervention. Compared to other interventions, acamprosate and naltrexone cost the least and provide the most QALYs. If the effectiveness of MATs and counseling decreased, these interventions would still be cost-effective based on the commonly used $100,000 per QALY gained threshold. Several sensitivity and scenario analyses showed that our main findings are robust. CONCLUSIONS Among patients with compensated AC, MATs and counseling are extremely cost-effective, and in some cases cost-saving, interventions to prevent decompensation and improve health. Health policies (e.g. payer reimbursement) should emphasize and appropriately compensate for these interventions. LAY SUMMARY Alcohol use treatments, including physician counseling and medication-assisted therapies (MATs), improve the outcomes of patients with compensated alcohol-related cirrhosis, though use and access have remained suboptimal. In this study, we found that counseling and MATs are extremely cost-effective, and in some cases cost-saving, interventions to help patients with alcohol-related cirrhosis abstain from alcohol and improve their health. Wider use of these interventions should be encouraged.
Collapse
Affiliation(s)
- Anton L.V. Avanceña
- Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA,Corresponding author: Anton Avanceña, Department of Health Management and Policy, University of Michigan School of Public Health, 1415 Washington Heights, SPH II, Ann Arbor, MI 48109. . Phone: +1-734-0287. Fax: +1-734-764-4338
| | - Nicholas Miller
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Sarah E. Uttal
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
| | - David W. Hutton
- Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA,Department of Industrial and Operations Engineering, College of Engineering, University of Michigan, Ann Arbor, MI, USA
| | - Jessica L. Mellinger
- Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
19
|
Davey MG, Ryan ÉJ, Davey MS, Lowery AJ, Miller N, Kerin MJ. Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis. Br J Surg 2021; 108:622-631. [PMID: 33963374 PMCID: PMC10364926 DOI: 10.1093/bjs/znab103] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Revised: 01/06/2021] [Accepted: 02/25/2021] [Indexed: 12/29/2022]
Abstract
BACKGROUND Uncertainty exists regarding the clinical relevance of programmed cell death ligand 1 (PD-L1) expression in breast cancer. METHODS A systematic review was performed in accordance with PRISMA guidelines. Observational studies that compared high versus low expression of PD-L1 on breast cancer cells were identified. Log hazard ratios (HRs) for disease-free and overall survival and their standard errors were calculated from Kaplan-Meier curves or Cox regression analyses, and pooled using the inverse-variance method. Dichotomous variables were pooled as odds ratios (ORs) using the Mantel-Haenszel method. RESULTS Sixty-five studies with 19 870 patients were included; 14 404 patients were classified as having low and 4975 high PD-L1 expression. High PD-L1 was associated with achieving a pathological complete response following neoadjuvant chemotherapy (OR 3.30, 95 per cent confidence interval 1.19 to 9.16; P < 0.01; I2 = 85 per cent). Low PD-L1 expression was associated with human epidermal growth factor receptor 2 (OR 3.98, 1.81 to 8.75; P < 0.001; I2 = 96 per cent) and luminal (OR 14.93, 6.46 to 34.51; P < 0.001; I2 = 99 per cent) breast cancer subtypes. Those with low PD-L1 had favourable overall survival rates (HR 1.30, 1.05 to 1.61; P = 0.02; I2 = 85 per cent). CONCLUSION Breast cancers with high PD-L1 expression are associated with aggressive clinicopathological and immunohistochemical characteristics and are more likely to achieve a pathological complete response following neoadjuvant chemotherapy. These breast cancers are, however, associated with worse overall survival outcomes.
Collapse
Affiliation(s)
- M G Davey
- Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.,Department of Surgery, Galway University Hospitals, Galway, Ireland
| | - É J Ryan
- Department of Surgery, Galway University Hospitals, Galway, Ireland.,Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - M S Davey
- Department of Surgery, Galway University Hospitals, Galway, Ireland.,Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - A J Lowery
- Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.,Department of Surgery, Galway University Hospitals, Galway, Ireland
| | - N Miller
- Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.,Department of Surgery, Galway University Hospitals, Galway, Ireland
| | - M J Kerin
- Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.,Department of Surgery, Galway University Hospitals, Galway, Ireland
| |
Collapse
|
20
|
Waldron RM, Moloney BM, Gilligan K, Lowery AJ, Joyce MR, Holian E, Kerin MJ, Miller N. MicroRNAs as biomarkers of multimodal treatment for rectal cancer. Br J Surg 2021; 108:e260-e261. [PMID: 33880499 DOI: 10.1093/bjs/znab111] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2020] [Revised: 01/13/2021] [Accepted: 02/28/2021] [Indexed: 01/27/2023]
Affiliation(s)
- R M Waldron
- Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland
| | - B M Moloney
- Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland
| | - K Gilligan
- Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland
| | - A J Lowery
- Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland
| | - M R Joyce
- Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland
| | - E Holian
- School of Mathematics, Statistics and Applied Mathematics, National University of Ireland, Galway, Ireland
| | - M J Kerin
- Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland
| | - N Miller
- Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland
| |
Collapse
|
21
|
Bauml J, Mick R, Mccoach C, Weiss J, Marrone K, Nieva J, Villaruz L, Levy B, Moreno R, Murkherji R, Sun F, Schwartzman W, Shaverdashvili K, Wang X, Shah M, Woodley J, Miller N, Succe C, Ullah T, Lovly C, Doebele R, Iams W, Horn L, Dowell J, Liu G, Leighl N, Patil T, Liu S, Velcheti V, Aisner D, Camidge R. FP14.06 Multicenter Analysis of Mechanisms of Resistance to Osimertinib (O) in EGFR Mutated NSCLC: An ATOMIC Registry Study. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
22
|
Bunn DC, Dias de Oliveira E, Springborn F, Gonzalez-Meler MA, Miller N. Contribution of Larvae Developing on Corn and Dry Beans to the Adult Population of Western Bean Cutworm in Michigan. Environ Entomol 2021; 50:232-237. [PMID: 33205188 DOI: 10.1093/ee/nvaa135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Indexed: 06/11/2023]
Abstract
The western bean cutworm, Striacosta albicosta (Smith) (Lepidoptera: Noctuidae), is historically a pest of both corn (Zea mays L. (Poales: Poaceae)) and dry beans (Phaseolus sp. L. (Fabales: Fabaceae)) in the western Great Plains. However, it has recently undergone an eastward range expansion establishing itself across the Corn Belt in 25 states and 4 Canadian provinces. To mitigate the effects of infestation in Michigan, foliar insecticides are used in dry beans, whereas management of the pest in corn relies more heavily on the use of Bt-expressing hybrids. In this study stable carbon isotope analysis was used to determine what crop adult moths developed on as larvae with analysis showing that very few of the adult moths developed on dry beans. These results suggest that beans and corn are not suitable as co-refuges and that mainly adults which developed on corn are contributing to the next generation of western bean cutworm in Michigan.
Collapse
Affiliation(s)
- Dakota C Bunn
- Department of Biological Sciences, Illinois Institute of Technology, Chicago, IL
| | - Eduardo Dias de Oliveira
- Ecology and Evolution, Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL
| | | | - Miquel A Gonzalez-Meler
- Ecology and Evolution, Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL
| | - Nicholas Miller
- Department of Biological Sciences, Illinois Institute of Technology, Chicago, IL
| |
Collapse
|
23
|
Helseth DL, Gulukota K, Miller N, Yang M, Werth T, Sabatini LM, Bouma M, Dunnenberger HM, Wake DT, Hulick PJ, Kaul KL, Khandekar JD. Flype: Software for enabling personalized medicine. Am J Med Genet C Semin Med Genet 2020; 187:37-47. [PMID: 33270363 PMCID: PMC7984435 DOI: 10.1002/ajmg.c.31867] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Revised: 11/19/2020] [Accepted: 11/20/2020] [Indexed: 02/02/2023]
Abstract
The advent of next generation DNA sequencing (NGS) has revolutionized clinical medicine by enabling wide‐spread testing for genomic anomalies and polymorphisms. With that explosion in testing, however, come several informatics challenges including managing large amounts of data, interpreting the results and providing clinical decision support. We present Flype, a web‐based bioinformatics platform built by a small group of bioinformaticians working in a community hospital setting, to address these challenges by allowing us to: (a) securely accept data from a variety of sources, (b) send orders to a variety of destinations, (c) perform secondary analysis and annotation of NGS data, (d) provide a central repository for all genomic variants, (e) assist with tertiary analysis and clinical interpretation, (f) send signed out data to our EHR as both PDF and discrete data elements, (g) allow population frequency analysis and (h) update variant annotation when literature knowledge evolves. We discuss the multiple use cases Flype supports such as (a) in‐house NGS tests, (b) in‐house pharmacogenomics (PGX) tests, (c) dramatic scale‐up of genomic testing using an external lab, (d) consumer genomics using two external partners, and (e) a variety of reporting tools. The source code for Flype is available upon request to the authors.
Collapse
Affiliation(s)
- Donald L Helseth
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Kamalakar Gulukota
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Nicholas Miller
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Mathew Yang
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Tom Werth
- Health Information Technology, NorthShore University HealthSystem, Skokie, Illinois, USA
| | - Linda M Sabatini
- Department of Pathology, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Mike Bouma
- Department of Pathology, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Henry M Dunnenberger
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Dyson T Wake
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Peter J Hulick
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA.,Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Karen L Kaul
- Department of Pathology, NorthShore University HealthSystem, Evanston, Illinois, USA
| | - Janaradan D Khandekar
- Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA.,Kellogg Cancer Center, NorthShore University HealthSystem, Evanston, Illinois, USA
| |
Collapse
|
24
|
Bogema DR, McKinnon J, Liu M, Hitchick N, Miller N, Venturini C, Iredell J, Darling AE, Roy Chowdury P, Djordjevic SP. Whole-genome analysis of extraintestinal Escherichia coli sequence type 73 from a single hospital over a 2 year period identified different circulating clonal groups. Microb Genom 2020; 6. [PMID: 30810518 PMCID: PMC7067039 DOI: 10.1099/mgen.0.000255] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Sequence type (ST)73 has emerged as one of the most frequently isolated extraintestinal pathogenic Escherichia coli. To examine the localized diversity of ST73 clonal groups, including their mobile genetic element profile, we sequenced the genomes of 16 multiple-drug resistant ST73 isolates from patients with urinary tract infection from a single hospital in Sydney, Australia, between 2009 and 2011. Genome sequences were used to generate a SNP-based phylogenetic tree to determine the relationship of these isolates in a global context with ST73 sequences (n=210) from public databases. There was no evidence of a dominant outbreak strain of ST73 in patients from this hospital, rather we identified at least eight separate groups, several of which reoccurred, over a 2 year period. The inferred phylogeny of all ST73 strains (n=226) including the ST73 clone D i2 reference genome shows high bootstrap support and clusters into four major groups that correlate with serotype. The Sydney ST73 strains carry a wide variety of virulence-associated genes, but the presence of iss, pic and several iron-acquisition operons was notable.
Collapse
Affiliation(s)
- D R Bogema
- Elizabeth Macarthur Agricultural Institute, NSW Department of Primary Industries, Menangle, NSW 2568, Australia.,The ithree Institute, University of Technology Sydney, NSW 2007, Australia
| | - J McKinnon
- The ithree Institute, University of Technology Sydney, NSW 2007, Australia
| | - M Liu
- The ithree Institute, University of Technology Sydney, NSW 2007, Australia
| | - N Hitchick
- San Pathology, Sydney Adventist Hospital, Wahroonga, NSW 2076, Australia
| | - N Miller
- San Pathology, Sydney Adventist Hospital, Wahroonga, NSW 2076, Australia
| | - C Venturini
- Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia
| | - J Iredell
- Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia
| | - A E Darling
- The ithree Institute, University of Technology Sydney, NSW 2007, Australia
| | - P Roy Chowdury
- The ithree Institute, University of Technology Sydney, NSW 2007, Australia
| | - S P Djordjevic
- The ithree Institute, University of Technology Sydney, NSW 2007, Australia
| |
Collapse
|
25
|
Mendell J, Sahenk Z, Lehman K, Nease C, Lowes L, Miller N, Iammarino M, Alfano L, Vaiea J, Al-Zaidy S, Lewis S, Church K, Shell R, Potter R, Griffin D, Pozsgai E, Hogan M, Rodino-Klapac L. DMD – THERAPY. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.277] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
26
|
Iammarino M, Powers B, Miller N, Shannon K, Alfano L, Lowes L. SMA - CLINICAL. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Rodino-Klapac L, Pozsgai E, Lewis S, Griffin D, Meadows A, Lehman K, Church K, Miller N, Iammarino M, Lowes L, Mendell J. LIMB GIRDLE MUSCULAR DYSTROPHIES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.143] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Powers B, Alcock L, Iammarino M, James M, Miller N, Hilsden H, Shannon K, Lowes L, Alfano L. OUTCOME MEASURES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
29
|
Mendell J, Shell R, Lehman K, McColly M, Lowes L, Alfano L, Miller N, Iammarino M, Church K, Ogrinc F, Ouyang H, Kernbauer E, Joshi S, Sproule D, Meriggioli M, Feltner D, Al-Zaidy S. SMA – THERAPY. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.260] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
30
|
Alfano L, James M, Miller N, Muni-Lofra R, Iammarino M, Moat D, Powers B, Sodhi J, McCallum M, Shannon K, Eagle M, Mayhew A, Lowes L. OUTCOME MEASURES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Iammarino M, Miller N, Alfano L, Powers B, Shannon K, Connolly A, Waldrop M, Tsao C, Sahenk Z, Flanigan K, Mendell J, Lowes L. OUTCOME MEASURES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
32
|
Miller N, Iammarino M, Alfano L, Powers B, Shannon K, Nease C, Lehman K, Mendell J, Lowes L. LIMB GIRDLE MUSCULAR DYSTROPHIES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Lowes L, Miller N, Iammarino M, Powers B, Shannon K, Alfano L. OUTCOME MEASURES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
34
|
Patel D, Ghali F, Meagher M, Bradshaw A, Patel S, Dutt R, Miller N, Keiner C, Cotta B, Murphy J, Derweesh I. The impact of delay in time to surgery on outcomes of localized renal cell carcinoma: Analysis based on tumor size. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33204-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
35
|
Dutt R, Meagher M, Patil D, Saito K, Patel D, Ghali F, Keiner C, Miller N, Bradshaw A, Wan F, Yasuda Y, Fujii Y, Master V, Derweesh I. Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32709-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
36
|
Patel D, Ghali F, Dutt R, Meagher M, Keiner C, Miller N, Murphy J, Derweesh I. The impact of metastasis location on overall survival among patients with renal cell carcinoma. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33443-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
37
|
Rodriguez JA, Rubio-Gomez H, Roa AA, Miller N, Eckardt PA. Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report. IDCases 2020; 20:e00762. [PMID: 32368493 PMCID: PMC7186517 DOI: 10.1016/j.idcr.2020.e00762] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Accepted: 04/06/2020] [Indexed: 01/23/2023] Open
Abstract
Coronavirus 2 (SARS-CoV-2) is now considered a pandemic causing Coronavirus disease (COVID-19), multiple fatalities and morbidities which have been associated with it worldwide. We report a severe pneumonia causing acute respiratory distress syndrome due to a coinfection with SARS-COV-2 and Parainfluenza 4 virus in a Hispanic 21 year old male in Florida, USA. The case represents the importance of prompt diagnosis and awareness of the potential co-infection with other respiratory viruses and this novel deadly virus.
Collapse
Affiliation(s)
- Jose A Rodriguez
- Department of Internal Medicine, Memorial Healthcare System, Pembroke Pines, FL, USA
| | - Heysu Rubio-Gomez
- Division of Infectious Disease, Memorial Regional Hospital, Memorial Healthcare System, Hollywood, FL, USA
| | - Alejandra A Roa
- Department of Internal Medicine, Memorial Healthcare System, Pembroke Pines, FL, USA
| | - N Miller
- Microbiology and Molecular Infectious Disease Pathology Consultants of South Broward, LLC, Memorial Healthcare System, Hollywood, FL, USA
| | - Paula A Eckardt
- Division of Infectious Disease, Memorial Regional Hospital, Memorial Healthcare System, Hollywood, FL, USA
| |
Collapse
|
38
|
Holderness E, Miller N, Cawkwell P, Bolton K, Meteer M, Pustejovsky J, Hall MH. Analysis of risk factor domains in psychosis patient health records. J Biomed Semantics 2019; 10:19. [PMID: 31672168 PMCID: PMC6823956 DOI: 10.1186/s13326-019-0210-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Accepted: 09/09/2019] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Readmission after discharge from a hospital is disruptive and costly, regardless of the reason. However, it can be particularly problematic for psychiatric patients, so predicting which patients may be readmitted is critically important but also very difficult. Clinical narratives in psychiatric electronic health records (EHRs) span a wide range of topics and vocabulary; therefore, a psychiatric readmission prediction model must begin with a robust and interpretable topic extraction component. RESULTS We designed and evaluated multiple multilayer perceptron and radial basis function neural networks to predict the sentences in a patient's EHR that are associated with one or more of seven readmission risk factor domains that we identified. In contrast to our baseline cosine similarity model that is based on the methodologies of prior works, our deep learning approaches achieved considerably better F1 scores (0.83 vs 0.66) while also being more scalable and computationally efficient with large volumes of data. Additionally, we found that integrating clinically relevant multiword expressions during preprocessing improves the accuracy of our models and allows for identifying a wider scope of training data in a semi-supervised setting. CONCLUSION We created a data pipeline for using document vector similarity metrics to perform topic extraction on psychiatric EHR data in service of our long-term goal of creating a readmission risk classifier. We show results for our topic extraction model and identify additional features we will be incorporating in the future.
Collapse
Affiliation(s)
- Eben Holderness
- Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Mill St, Belmont, MA, USA.,Brandeis University Department of Computer Science, South St, Waltham, MA, USA
| | - Nicholas Miller
- Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Mill St, Belmont, MA, USA
| | - Philip Cawkwell
- Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Mill St, Belmont, MA, USA
| | - Kirsten Bolton
- Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Mill St, Belmont, MA, USA
| | - Marie Meteer
- Brandeis University Department of Computer Science, South St, Waltham, MA, USA
| | - James Pustejovsky
- Brandeis University Department of Computer Science, South St, Waltham, MA, USA
| | - Mei-Hua Hall
- Psychosis Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Mill St, Belmont, MA, USA.
| |
Collapse
|
39
|
Rodino-Klapac L, Pozsgai E, Lewis S, Griffin D, Meadows A, Lehman K, Church K, Miller N, Iammarino M, Lowes L, Mendell J. CLINICAL TRIAL HIGHLIGHTS. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.592] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Alfano L, Miller N, Iammarino M, Lowes L. P.215Utility of functional outcomes in adults with spinal muscular atrophy. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
41
|
Mah M, Slawinski M, Cripe L, Camino E, Al-Zaidy S, Hassan S, Jackson J, Lowes L, Iammarino M, Miller N, Alfano L, Lehman K, Mendell J, Hor K. DMD CLINICAL. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Mendell J, Shell R, Lehman K, McColly M, Lowes L, Alfano L, Miller N, Iammarino M, Church K, Ogrinc F, Ouyang H, Kernbauer E, Shah S, L'Italien J, Sproule D, Feltner D, Al-Zaidy S. P.351Gene-replacement therapy (GRT) in spinal muscular atrophy type 1 (SMA1): long-term follow-up from the onasemnogene abeparvovec phase 1/2a clinical trial. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
43
|
Alfano L, Miller N, Iammarino M, Lowes L. P.193The neuromuscular gross motor outcome as an outcome measure in spinal muscular atrophy. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Miller N, Alfano L, Iammarino M, Moore-Clingenpeel M, Tsao C, Waldrop M, Flanigan K, Mendell J, Lowes L. EP.89Clinical trials in young boys and infants with DMD: how do you handle maturation? Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Lowes L, Alfano L, Chen D, Nelson L, Miller N, Iammarino M, McColly M, Mendell J, Rust S. P.214Presymptomatic spinal muscular atrophy: reality or myth? Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.328] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
46
|
Waldrop M, Lowes L, Toops J, Alfano L, Miller N, Iammarino M, Kotha K, Paul G, Moore-Clingenpeel M, Tsao C, Noritz G, Shell R, Flanigan K. P.365Clinical outcomes in patients with spinal muscular atrophy type 1, 2 or 3 after 1 year of nusinersen therapy. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
47
|
Jackson J, Leslie C, Cotto J, Korth C, Mah M, Hor K, Cripe L, Camino E, Al-Zaidy S, Hassan S, Vannatta K, Lowes L, Iammarino M, Miller N, Alfano L, Lehman K, Mendell J. DMD BRAIN. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Iammarino M, Miller N, Alfano L, Lehman K, Rodino-Klapac L, Mendell J, Lowes L. P.174Establishing divergent phenotypes in limb girdle muscular dystrophies. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.229] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Barakat C, Barroso R, Alvarez M, Rauch J, Miller N, Bou-Sliman A, De Souza EO. The Effects of Varying Glenohumeral Joint Angle on Acute Volume Load, Muscle Activation, Swelling, and Echo-Intensity on the Biceps Brachii in Resistance-Trained Individuals. Sports (Basel) 2019; 7:sports7090204. [PMID: 31487841 PMCID: PMC6783981 DOI: 10.3390/sports7090204] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 08/31/2019] [Accepted: 09/02/2019] [Indexed: 12/04/2022] Open
Abstract
There is a paucity of data on how manipulating joint angles during isolation exercises may impact overall session muscle activation and volume load in resistance-trained individuals. We investigated the acute effects of varying glenohumeral joint angle on the biceps brachii with a crossover repeated measure design with three different biceps curls. One session served as the positive control (CON), which subjects performed 9 sets of bicep curls with their shoulder in a neutral position. The experimental condition (VAR), varied the glenohumeral joint angle by performing 3 sets in shoulder extension (30°), 3 sets neutral (0°), and 3 sets in flexion (90°). Volume load and muscle activation (EMG) were recorded during the training sessions. Muscle swelling and strain were assessed via muscle thickness and echo-intensity responses at pre, post, 24 h, 48 h, and 72 h. There were no significant differences between conditions for most dependent variables. However, the overall session EMG amplitude was significantly higher (p = 0.0001) in VAR compared to CON condition (95%-CI: 8.4% to 23.3%). Our findings suggest that varying joint angles during resistance training (RT) may enhance total muscle activation without negatively affecting volume load within a training session in resistance-trained individuals.
Collapse
Affiliation(s)
- Christopher Barakat
- Department of Health Science and Human Performance, University of Tampa, Tampa, FL 33606, USA.
| | - Renato Barroso
- School of Physical Education, University of Campinas, Campinas 13083-851, Brazil.
| | - Michael Alvarez
- Department of Health Science and Human Performance, University of Tampa, Tampa, FL 33606, USA.
| | - Jacob Rauch
- Department of Health Science and Human Performance, University of Tampa, Tampa, FL 33606, USA.
| | - Nicholas Miller
- Department of Health Science and Human Performance, University of Tampa, Tampa, FL 33606, USA.
| | - Anton Bou-Sliman
- Department of Health Science and Human Performance, University of Tampa, Tampa, FL 33606, USA.
| | - Eduardo O De Souza
- Department of Health Science and Human Performance, University of Tampa, Tampa, FL 33606, USA.
| |
Collapse
|
50
|
Dann S, Chionis J, Eisele K, Zhang Q, Liu C, Yuan J, Miller N, Murray B, Xu M, Solowiej J, Wei P, Weinrich S, Sutton S, Behenna D, Ninkovic S, Hoffman R, Freeman-Cook K, Jessen B, Huser N, Zhang C, Visswanathan R, Boras B, VanArsdale T, White MA. Abstract P6-20-06: Withdrawn. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p6-20-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Citation Format: Dann S, Chionis J, Eisele K, Zhang Q, Liu C, Yuan J, Miller N, Murray B, Xu M, Solowiej J, Wei P, Weinrich S, Sutton S, Behenna D, Ninkovic S, Hoffman R, Freeman-Cook K, Jessen B, Huser N, Zhang C, Visswanathan R, Boras B, VanArsdale T, White MA. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P6-20-06.
Collapse
Affiliation(s)
- S Dann
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - J Chionis
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - K Eisele
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - Q Zhang
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - C Liu
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - J Yuan
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - N Miller
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - B Murray
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - M Xu
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - J Solowiej
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - P Wei
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - S Weinrich
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - S Sutton
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - D Behenna
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - S Ninkovic
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - R Hoffman
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - K Freeman-Cook
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - B Jessen
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - N Huser
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - C Zhang
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - R Visswanathan
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - B Boras
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - T VanArsdale
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| | - MA White
- Pfizer Oncology Research Division, La Jolla, CA; Pfizer Medicinal Sciences, La Jolla, CA
| |
Collapse
|